Dr. Sandra Joy Ginsberg, MD

Dr. Ginsberg practices at Drs Adelson and Ginsberg in Washington, District of Columbia.

Dr. Ginsberg's NPI, 1902823479, was assigned on July 17, 2006. Dr. Ginsberg graduated from Pritzker School of Medicine in 1972. Dr. Ginsberg holds District of Columbia license MD19759.

Dr. Ginsberg's primary practice is Drs Adelson and Ginsberg, at 1145 19th NW St, Washington, DC 20036 in District Of Columbia County. The practice phone is (202) 296-2180.

Dr. Ginsberg's primary practice is Drs Adelson and Ginsberg in Washington, District of Columbia. Dr. Ginsberg is also affiliated with MedStar Washington Hospital Center. Dmand AI also links Dr. Ginsberg to 3 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ginsberg practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Ginsberg's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Ginsberg is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Ginsberg's licenses on file in 4 states: District of Columbia, Maryland, New York and Washington.

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, fluid and electrolyte imbalances, lung cancer, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Ginsberg treats.

CMS data shows 1,258 Medicare services from Dr. Ginsberg across 9 procedure codes in 2024, for 321 Medicare patients. Medicare paid $131,938 for them. Every service was in an office.

CMS counts 321 Medicare patients who saw Dr. Ginsberg in 2024. The largest group is 75 to 84, with 156 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ginsberg's median patient age at 75, with 66% women.

In 2024, Dr. Ginsberg wrote 2,492 Medicare Part D claims for 245 patients. 88% of them were for generic drugs. CMS names the drug for 1,918 of them, across 53 drugs with 11 or more claims each, at $289,458 in total drug cost. In 2023, CMS named 1,327 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Ginsberg for performance year 2024, reported individually. Dr. Ginsberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Ginsberg. The most frequent topics are Drug Evaluation, Adenocarcinoma and Antineoplastic Agents. Dr. Ginsberg has published most often in Am J Clin Oncol. Dr. Ginsberg's most frequent co-authors are Jonathan B. Blitzer, MD, Daniel Budman and James Mitchell Granfortuna, MD.

CMS Open Payments shows 156 general payments to Dr. Ginsberg from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Puma Biotechnology, Inc. paid the most, $1,236.

Dr. Ginsberg graduated from Pritzker School of Medicine in 1972. Dr. Ginsberg is a member of ASCO.

Dr. Ginsberg is in network with 8 carriers, including Aetna, United Healthcare and CareFirst BlueCross BlueShield. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.